Besides, it has been shown that modifying WNT/β‐catenin and JAK‐STAT pathways, and also inhibiting the NF-κB pathway, may be involved in TRAIL-induced apoptosis in NSCLC xenografts following treatment with apigenin plus TRAIL (5). The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.